Sign In
Buy LGND
$234.40
+1.64 (+0.705%)
At Close: Jun 03, 2026
Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates
06:04pm, Monday, 03'rd May 2021
Ligand (LGND) delivered earnings and revenue surprises of 34.29% and -15.61%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Ligand Pharmaceuticals Q1 Earnings
04:58pm, Monday, 03'rd May 2021
Shares of Ligand Pharmaceuticals (NASDAQ:LGND) fell 7% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 58.43% over the past year to $1.41, w
Scalable Platform Business And Strong Pipeline Position Ligand For Long-Term Growth
12:10am, Thursday, 15'th Apr 2021
Scalable Platform Business And Strong Pipeline Position Ligand For Long-Term Growth
Why Is Ligand (LGND) Down 21.3% Since Last Earnings Report?
12:11pm, Friday, 05'th Mar 2021
Ligand (LGND) reported earnings 30 days ago. What's next for the stock?
4D Pharma Appointments Paul Maier to the Board as Non-Executive Director
07:05am, Monday, 01'st Mar 2021
LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome,
Stocks With The Highest Short Interest Rate: GameStop, ISun Inc
12:57pm, Thursday, 18'th Feb 2021
Retail investors have been on the hunt for the most shorted stocks to buy in the market this week. Share prices have reached record levels due to a rally of short squeezes.
Forget Gamestop! This Highly Shorted Stock Is a Strong Buy Now
06:40am, Tuesday, 09'th Feb 2021
The unusual biotech could be a bitter pill for short sellers to swallow.
Ligand (LGND) Q4 Earnings & Sales Top, 2021 Guidance Raised
09:50am, Thursday, 04'th Feb 2021
Ligand (LGND) reports better-than-expected fourth-quarter 2020 numbers. The company raises outlook for 2021.
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2020 Results - Earnings Call Transcript
02:15pm, Wednesday, 03'rd Feb 2021
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2020 Results - Earnings Call Transcript
Ligand Pharmaceuticals: Q4 Earnings Insights
07:58am, Wednesday, 03'rd Feb 2021
Shares of Ligand Pharmaceuticals (NASDAQ:LGND) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share rose 128.17% over the past year to $1.62, which beat the estim
Ligand Reports Fourth Quarter and Full Year 2020 Financial Results
07:30am, Wednesday, 03'rd Feb 2021
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and 12 months ended December 31, 2020 and provided an operating forecast a
Short-Sellers Have These 3 ETFs in Their Sights
12:31am, Wednesday, 03'rd Feb 2021
Should investors watch for a squeeze?
Gamestopping Biopharma: These Three Stocks May See A Short Squeeze Soon
06:47am, Sunday, 31'st Jan 2021
The GameStop effect will soon come to biopharma, an usually heavily-shorted sector. Here's a list of three of biopharma's more heavily-shorted stocks.
One Of The Most Shorted Names In Biotech: Ligand Pharmaceuticals
08:34pm, Friday, 29'th Jan 2021
One Of The Most Shorted Names In Biotech: Ligand Pharmaceuticals
New York, New York--(Newsfile Corp. - January 28, 2021) - Levi & Korsinsky, LLP, a national securities law firm that has recovered hundreds of millions of dollars for investors, announces that it has
